The Agentic AI Use Cases Already Transforming Clinical Trials

As clinical trials grow more complex, organizations are exploring how agentic AI can move beyond simple automation to support faster, smarter decision-making across the development lifecycle. Industry leaders from AstraZeneca, Syneos Health, Medable, and Acra share real-world perspectives on where traditional AI has delivered value, where it has fallen short, and how agentic systems are beginning to reshape trial operations.

The discussion examines practical applications across study startup, enrollment, trial conduct, and operational oversight, highlighting how AI agents can coordinate workflows, connect data across systems, and help reduce manual effort while maintaining human oversight. Panelists also explore the distinction between automation and transformation, including opportunities to improve protocol design, optimize resource allocation, and generate insights that influence strategic development decisions.

Beyond technology, the conversation addresses critical challenges around adoption, governance, change management, and measuring success. Learn which KPIs organizations are using to evaluate impact, how sponsors and CROs can align around shared outcomes, and what capabilities may define the next wave of AI-driven innovation in clinical development.

Access the full webinar to gain practical insights into the evolving role of agentic AI in clinical trials.